Previous Close | 0.5600 |
Open | 0.5406 |
Bid | 0.5000 x 0 |
Ask | 0.7978 x 0 |
Day's Range | 0.5406 - 0.5406 |
52 Week Range | 0.0471 - 0.9116 |
Volume | |
Avg. Volume | 13,106 |
Market Cap | 27.032M |
Beta (5Y Monthly) | -0.44 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.1800 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Collaboration with World Leading University, University of EdinburghMulti-Million Dollar Transformative Project for Long-Term CareFuture Partnering Opportunities VANCOUVER, British Columbia, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”) is pleased to announce it has signed a Collaborative Agreement with the University Court of the University of Edinburgh (“University of Edinburgh”). The University of Edinburgh is looking to utilize
Collaboration with World Leading University, University of EdinburghMulti-Million Dollar Transformative Project for Long-Term CareFuture Partnering Opportunities VANCOUVER, British Columbia, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”) is pleased to announce it has signed a Collaborative Agreement with the University Court of the University of Edinburgh (“University of Edinburgh”). The University of Edinburgh is looking to utilize
VANCOUVER, British Columbia, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Company” or “Treatment”), a healthcare tech company transforming patient care with AI-driven clinical insights, endorses the forward thinking emanating from a recent event in Washington comprising 25 of the nation’s leading experts on the appropriate use of artificial intelligence (AI) within healthcare. It is understood there are real challenges to the stability and sus